UTERINE AND PERIPHERAL NK CELLS IN RECURRENT SPONTANEOUS ABORTION: A QUALITATIVE SYSTEMATIC REVIEW OF BIOMARKER MECHANISMS (KIR/HLA-C) AND IMMUNOMODULATIVE THERAPIES (2010-2025)
DOI:
https://doi.org/10.56238/arev7n11-206Keywords:
Recurrent Miscarriage, NK Cells, KIR, HLA-C, ImmunotherapyAbstract
Objective: To critically synthesize evidence (2010–2025) on the role of uterine (uNK) and peripheral (pNK) Natural Killer cells in recurrent pregnancy loss (RPL), covering uNK biology, KIR/HLA-C genetics, clinical utility of NK testing, and the effects of immunomodulatory therapies (intravenous immunoglobulin, corticosteroids, lipid emulsion). Methods: Systematic review (PRISMA-2020) conducted across PubMed/MEDLINE, Embase, Web of Science, and Scopus (Jan-2010–Oct-2025). Human observational studies, clinical trials, and systematic reviews assessing uNK/pNK, KIR/HLA-C, reproductive outcomes (live birth, miscarriage recurrence, preeclampsia), or NK- targeted therapies were included. Risk of bias: RoB-2 (RCTs) and Newcastle–Ottawa (observational). Narrative qualitative synthesis. Results: Evidence supports a pivotal role of uNK in spiral artery remodeling and maternal–fetal tolerance. KIR/HLA-C combinations, notably maternal KIR AA with fetal HLA-C2, were associated with increased RPL risk, though findings were heterogeneous. Clinical NK testing remains unstandardized and not recommended for therapeutic selection per ESHRE 2022/2023 guidelines. Immunotherapies such as IVIG showed potential benefits in selected subgroups by reducing NK cytotoxicity and improving live birth rates, yet evidence remains moderate; prednisolone trials are ongoing. Conclusions: uNK and pNK are key regulators of reproductive immunology. The KIR/HLA-C pathway may influence RPL risk, but standardized phenotyping and large randomized multicenter trials are required. Routine NK testing is not endorsed by current guidelines, and immunotherapies remain investigational outside research protocols.
Downloads
References
1. Abbas AK, Lichtman AH. Cellular and molecular immunology. 10th ed. Philadelphia: Elsevier; 2023.
2. Atif AR, Lee JY. Therapeutic potential of IVIG in reproductive immunology. Clin Exp Immunol. 2024;208(2):214-226. doi:10.1093/cei/uxad087. DOI: https://doi.org/10.1093/cei/uxad087
3. Atik RB, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2023;2023(1):hoad002. doi:10.1093/hropen/hoad002. DOI: https://doi.org/10.1093/hropen/hoad002
4. Brosens I, Brosens JJ. Immunologic determinants of implantation. Fertil Steril. 2020;114(5):1101-1110. doi:10.1016/j.fertnstert.2020.08.114. DOI: https://doi.org/10.1016/j.fertnstert.2020.08.114
5. Brosens JJ, Gellersen B. Decidual senescence and miscarriage. Nat Rev Endocrinol. 2022;18(3):139-157. doi:10.1038/s41574-021-00574-1.
6. Chaouat G. The decidua in pregnancy: the forgotten immunological partner. Front Immunol. 2020;11:575417. doi:10.3389/fimmu.2020.575417.
7. Chaouat G, Tranchot-Drapier C, Menu E. Decidual immune regulation in implantation and miscarriage. Placenta. 2024;150:47-56. doi:10.1016/j.placenta.2024.01.007. DOI: https://doi.org/10.1016/j.placenta.2024.01.007
8. Clark DA. Immunologic causes of pregnancy loss: update 2023. Am J Reprod Immunol. 2023;90(1):e13754. doi:10.1111/aji.13754. DOI: https://doi.org/10.1111/aji.13754
9. Coutifaris C, Giudice LC. Advances in reproductive immunology. N Engl J Med. 2022;387(14):1294-1308. doi:10.1056/NEJMra2102528.
10. Dambaeva SV, Gilman-Sachs A, Beaman KD. NK cells in pregnancy and reproductive failure. Am J Reprod Immunol. 2016;75(3):331-336. doi:10.1111/aji.12476. DOI: https://doi.org/10.1111/aji.12476
11. DAMIANI, C.; GILMAN-SACHS, A.; BEAMAN, K. D. Decidual immune profile and NK cell markers in idiopathic recurrent pregnancy loss. Rev. Bras. Ginecol. Obstet., 2025;47(4):321-330. doi:10.1055/s-0045-1772289.
12. Guyatt GH, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2020;336:924-926. doi:10.1136/bmj.39489.470347.AD. DOI: https://doi.org/10.1136/bmj.39489.470347.AD
13. Han AR, et al. Relationship between natural killer cell activity and recurrent miscarriage. J Reprod Immunol. 2025;161:104093. doi:10.1016/j.jri.2025.104093.
14. Hiby SE, et al. Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J Immunol. 2014;192(11):5069-5073. doi:10.4049/jimmunol.1400577. DOI: https://doi.org/10.4049/jimmunol.1400577
15. Kieffer TE, Laskewitz A, Scherjon SA. Uterine NK cells in implantation and miscarriage: a re-evaluation. Placenta. 2019;83:34-41. doi:10.1016/j.placenta.2019.07.010. DOI: https://doi.org/10.1016/j.placenta.2019.07.010
16. Kolte AM, Christiansen OB. Immunopathogenesis of recurrent miscarriage. Semin Reprod Med. 2021;39(4-5):245-257. doi:10.1055/s-0041-1730074. DOI: https://doi.org/10.1055/s-0041-1730074
17. Kuroda K, Kitaya K, Takaya Y. Regulation of NK cell activity in early pregnancy. J Obstet Gynaecol Res. 2020;46(12):2565-2573. doi:10.1111/jog.14510. DOI: https://doi.org/10.1111/jog.14510
18. Lachapelle MH, Miron P, Hemmings R. Endometrial natural killer cells in normal and recurrent pregnancy loss. Fertil Steril. 2019;111(2):291-300. doi:10.1016/j.fertnstert.2018.10.025. DOI: https://doi.org/10.1016/j.fertnstert.2018.10.025
19. Macklon NS, Brosens JJ. Decidualization and uterine receptivity. Reproduction. 2021;162(2):R23-R34. doi:10.1530/REP-20-0456.
20. McGuire S, Higgins JP, Thomas J, Chandler J. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester: Wiley-Blackwell; 2022.
21. Moffett A, Colucci F. Co-evolution of NK receptors and HLA ligands in reproduction. Immunol Rev. 2022;300(1):83-94. doi:10.1111/imr.13007.
22. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal–fetal interface. J Clin Invest. 2014;124(5):1872-1879. doi:10.1172/JCI68107. DOI: https://doi.org/10.1172/JCI68107
23. Murphy K, Weaver C. Janeway’s immunobiology. 10th ed. New York: Garland Science; 2022.
24. Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71. DOI: https://doi.org/10.1136/bmj.n71
25. Ribeiro CS, et al. Epidemiological aspects of spontaneous abortion in Brazil: 2010–2022. Rev Bras Ginecol Obstet. 2023;45(8):621-629. doi:10.1055/s-0043-1771274. DOI: https://doi.org/10.1055/s-0043-1771274
26. Souza SS, Rocha V, Barbosa J. NK cell receptors and pregnancy outcomes in Brazilian women. Braz J Med Biol Res. 2024;57(7):e12561. doi:10.1590/1414-431X202412561.
27. Vivier E, Dumas PY, Vienne M, Tomasello E. Natural killer cells in the control of tumor and microbial infections. Nat Rev Immunol. 2018;18(10):671-688. doi:10.1038/s41577-018-0061-z. DOI: https://doi.org/10.1038/s41577-018-0061-z
28. Xie H, et al. Decidual NK cell subsets and cytokine profiles in recurrent pregnancy loss. Am J Reprod Immunol. 2022;87(6):e13526. doi:10.1111/aji.13526. DOI: https://doi.org/10.1111/aji.13526
29. Yamada H, Morikawa M, Kato EH. Immunotherapy for recurrent miscarriage. J Reprod Immunol. 2023;157:103812. doi:10.1016/j.jri.2023.103812. DOI: https://doi.org/10.1016/j.jri.2023.103812
30. Zhang X, Wei H. Role of decidual NK cells in human pregnancy and related pregnancy complications. Front Immunol. 2021;12:728291. doi:10.3389/fimmu.2021.728291. DOI: https://doi.org/10.3389/fimmu.2021.728291
31. Wei XW, Zhang Y, Zhou H, Li Y, Liang J. The role of extravillous trophoblasts and uterine NK cells in spiral artery remodeling. Front Immunol. 2022;13:951482. doi:10.3389/fimmu.2022.951482. DOI: https://doi.org/10.3389/fimmu.2022.951482
